These new data show deep, durable silencing of key hepatitis B viral markers after a single dose of Chroma’s epigenetic editor, highlighting the potential of our approach to treat chronic #HBV. How did we get here? @jaffaeb is back for another data 🧵. #EpigeneticEditing 1/7

#Healthcareproviders: Our partner LUNGevity Foundation has a webpage tailored to help you navigate #biomarker testing in non-small cell #lungcancer. Visit #NoOneMissed to find insightful resources to help you guide your #NSCLC patients to an optimal care plan: no1missed.org/44fHyYc

Honored to advocate this past week at #Head2Hill on behalf of National Brain Tumor Society, FIU Medicine, Cure Glioblastoma, Elsa’s Touch Foundation, and brain cancer warriors to increase brain tumor research funding and support PCHETA! 🧠🎗️#beatbraincancer #DIPG #CureGBM #advocacy #StrongerTogether

Your support during #CCAM made an immediate impact on the important work underway to find a cure and ensure a better quality of life for children living with #braintumors. Thank you for taking action to fuel the #breakthroughsahead for #pediatricbraincancer.

Heroes in the fight against #pancreaticcancer are all around us, and if you're reading this, you're one of them! 🦸‍♀️💥💜 Thank you for all you do to support patients and their families every day! Send this to your hero today! 📬

Join us on Sunday, October 15th at 7 p.m. ET for our monthly Brain Tumor Support Conversation. Anyone who has been affected by a #braintumor is encouraged to speak in this welcoming space: bit.ly/BTSupportConvos

In this week's episode, the show's new co-host Katy Peters sits down with David Arons and Vinay K Puduvalli to discuss what brain tumors are, how they occur, and how organizations like National Brain Tumor Society support those living with them. Listen now: bit.ly/3PROG8a Daniel José Correa, MD, MSc

Thank you to the sponsors of the #Race4HopePA. Because of your support, we will hold a moving & memorable event this weekend with thousands of participants motivated to conquer & cure #braintumors — once & for all! Learn more about our Race for Hope PA: bit.ly/46r8ruo

A special thanks to our sponsors of the #Race4HopePA. Because of your support, the #braintumor community will come together today for an inspiring and memorable event to fuel momentum for our cause. Together, we can defeat #braintumors — once and for all: bit.ly/46r8ruo

Yesterday GCAR staff participated in American Brain Tumor Association 's Los Angeles #BT5K to support the #braintumor community and fundraising for vital research. #GBMAGILE Imaging Lead and Biomarker Committee Member Ben Ellingson of UCLA Brain Tumor Imaging Laboratory spoke at the event. #btsm 🧠

We've created the DNA Damage Response Consortium, a pioneering network of world-class researchers. Watch to learn why #BTSM

Very excited to have been co-leading this wonderful consortium with Drs. Nat Agar and Kirk Tanner this year! Watch👇🏽for a great review/primer/rationale on targeting the DDR in brain tumors! Yale Radiation Oncology Residency Yale Cancer Center National Brain Tumor Society

We are proud to partner with the National Brain Tumor Society on their DNA Damage Response Consortium! #BTSM National Brain Tumor Society Ranjit Bindra,MD/PhD Yale Neuroscience Yale Department of Neurosurgery Smilow Cancer Hospital Yale Radiation Oncology Residency Yale School of Medicine Yale New Haven Hosp

A special thanks to our #NewEnglandBTWalk sponsors. Because of your support, the #braintumor community will come together today for an inspiring & memorable event to fuel momentum for our cause. Together, we can defeat #braintumors — once & for all: bit.ly/45E1CV9

I’m proud to join National Brain Tumor Society and fellow brain tumor advocates in urging Bob Good Mark Warner Senator Tim Kaine to support increased brain tumor research funding and other patient-first priorities of the brain tumor community. #Head2Hill #GoGrayInMay p2a.co/twitterimage?i…

GCAR had the pleasure of attending the National Brain Tumor Society Glioblastoma Awareness Day reception in D.C. #GBMDay is a day dedicated to raising awareness about #glioblastoma, a deadly type of brain cancer with no cure and limited treatment options. GCAR is dedicated to making a

The end of July marks 5 years since the first patient enrolled in GBM AGILE. Driven by the lack of progress and determined to do better for patients, a group of physicians, researchers, patient advocates, regulators, and industry came together to spur change. The result was GBM

Centering attendees at a scientific conference on the ‘why’ reminds us that the data/work presented isn’t just about advancing science—it’s about advancing meaningful, patient-centered progress.” Patient advocates help bring this focus to the forefront, ensuring that research

(Massachusetts, USA) This exciting study led by a sympathetic researcher has been struggling to recruit for years. It now has this webpage which is new to me. Please like +/or RT. 🙏 rally.massgeneralbrigham.org/study/me_cfs_p… #MyalgicEncephalomyelitis #ChronicFatigueSyndrome #MEcfs #CFS #PwME

A new brain cancer drug has shown it can delay tumor progression. “This is the most exciting thing I’ve ever encountered,” said one neuro-oncologist. trib.al/1IQO5Wy